ÂÜÀòÂÒÂ×

Justin McCarthy has over 27 years of experience in the pharmaceutical industry, with expertise in pricing, market access, global health policy, legal and compliance. In his most recent role, he led the Patient & Health Impact (PHI) team at Pfizer, one of the world¡¯s premier innovative biopharmaceutical companies whose global portfolio includes medicines and vaccines. He led a team of experts in health economics and outcomes research, real-world data and analytics, patient-centered outcomes assessment, market access, pricing, strategy and contracting, to generate evidence of the value of Pfizer medicines and vaccines and negotiate with governments and payers around the world to ensure access for patients. He also formed a team to explore novel approaches to bring medicines to the market through innovative partnerships and payment models.

Previously, Justin led Pfizer¡¯s Global Policy & International Public Affairs efforts, responsible for defining Pfizer¡¯s public policy positions and advancing government and public affairs strategies internationally. Additionally, Justin was Chief Counsel for Pfizer¡¯s Worldwide Research and Development division, advising on regulatory, licensing and clinical trial issues, and overseeing global intellectual property activities.

Justin serves as a health policy and market access advisor, and has previously served on the Secretary¡¯s Advisory Committee for Human Subject Protection, Subcommittee on Harmonization.